Original Article

Fibrinogen in COVID-19: Interpreting From Current Evidence

Year: 2020 | Month: June | Volume 9 | Issue 1

References (38)

1.Palta S, Saroa R, Palta A. 2014. Overview of the coagulation system. Indian J Anaesth., 58(5): 515.

View at Google Scholar

2.Pieters M, Wolberg AS. 2019. Fibrinogen and fibrin: An illustrated review. Res Pract Thromb Haemost., 3(2): 161–72.

View at Google Scholar

3.Fish RJ, Neerman-Arbez M. 2012. Fibrinogen gene regulation. Thromb Haemost., 108(09): 419–26.

View at Google Scholar

4.Jennewein C, Tran N, Paulus P, Ellinghaus P, Eble JA, Zacharowski K. 2011. Novel Aspects of Fibrin(ogen) Fragments during Inflammation. Mol Med., 17(5–6): 568– 73.

View at Google Scholar

5.Khalil R, Al-Humadi N. 2020. Types of acute phase reactants and their importance in vaccination (Review). Biomed Rep [Internet]. 2020 Feb 11 [cited 2020 Dec 6]; Available from: http:// www.spandidos-publications.com/10.3892/ br.2020.1276

View at Google Scholar

6.Davalos D, Akassoglou K. 2012. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol., 34(1): 43–62.

View at Google Scholar

7.Delvaeye M, Conway EM. 2009. Coagulation and innate immune responses: can we view them separately? Blood, 114(12): 2367–74.

View at Google Scholar

8.Luyendyk JP, Schoenecker JG, Flick MJ. 2019. The multifaceted role of fibrinogen in tissue injury and inflammation. Blood, 133(6): 511–20.

View at Google Scholar

9.Thachil J. 2020. The protective rather than prothromboticfibrinogen in COVID-19 and other inflammatory states. J Thromb Haemost, 18(8): 1849–52.

View at Google Scholar

10.Ng LF, Hibberd ML, Ooi E-E, Tang K-F, Neo S-Y, Tan J, et al. 2004. A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection. BMC Infect Dis., 4(1): 34.

View at Google Scholar

11.Han M, Yan W, Huang Y, Yao H, Wang Z, Xi D, et al. 2008. The Nucleocapsid Protein of SARS-CoV Induces Transcription of hfgl2 Prothrombinase Gene Dependent on C/EBP Alpha. J Biochem. (Tokyo). 144(1): 51–62.

View at Google Scholar

12.Simpson-Haidaris PJ, Courtney M-A, Wright TW, Goss R, Harmsen A, Gigliotti F. 1998. Induction of Fibrinogen Expression in the Lung Epithelium during Pneumocystis carinii Pneumonia. Mansfield JM, editor. Infect Immun., 66(9): 4431–9.

View at Google Scholar

13.Duvoix A, Dickens J, Haq I, Mannino D, Miller B, Tal-Singer R, et al. 2013. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease: Table 1. Thorax. 68(7): 670–6.

View at Google Scholar

14.Carty CL, Heagerty P, Heckbert SR, Jarvik GP, Lange LA, Cushman M, et al. 2010. Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study. Ann Hum Genet., 74(1): 1–10.

View at Google Scholar

15.Nugroho J, Wardhana A, Mulia EP, Maghfirah I, Rachmi D. 2020. Elevated fibrinogen and fibrin degradation product are associated with poor outcome in COVID-19 patients: A meta-analysis. Clin Hemorheol Microcirc., 13: 1–11.

View at Google Scholar

16.Connors JM, Levy JH. 2020. COVID-19 and its implications for thrombosis and anticoagulation. Blood, 135(23): 2033–40.

View at Google Scholar

17.Han H, Yang L, Liu R, Liu F, Wu K, Li J, et al. 2020. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med CCLM. 58(7): 1116–20.

View at Google Scholar

18.Zou Y, Guo H, Zhang Y, Zhang Z, Liu Y, Wang J, et al. 2020. Analysis of coagulation parameters in patients with COVID-19 in Shanghai, China. Biosci Trends, 14(4): 285–9.

View at Google Scholar

19.Tang N, Li D, Wang X, Sun Z. 2020. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost., 18(4): 844–7.

View at Google Scholar

20.Wada H, Thachil J, Di Nisio M, Mathew P, Kurosawa S, Gando S, et al. 2013. Guidance for diagnosis and treatment of disseminated intravascular coagulation from harmonization of the recommendations from three guidelines. J Thromb Haemost., 11(4): 761–7.

View at Google Scholar

21.Hay?ro?lu M?, Ç?nar T, Tekke?in A?. 2020. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review. Rev Assoc Médica Bras., 66(6): 842–8.

View at Google Scholar

22.Li Q, Cao Y, Chen L, Wu D, Yu J, Wang H, et al. 2020. Hematological features of persons with COVID-19. Leukemia, 34(8): 2163–72.

View at Google Scholar

23.Aggarwal M, Dass J, Mahapatra M. 2020. Hemostatic Abnormalities in COVID-19: An Update. Indian J Hematol Blood Transfus., 36(4): 616–26.

View at Google Scholar

24.Kara H, Bayir A, Degirmenci S, Kayis SA, Akinci M, Ak A, et al. 2014. D-dimer and D-dimer/fibrinogen ratio in predicting pulmonary embolism in patients evaluated in a hospital emergency department. Acta Clin Belg., 69(4): 240–5.

View at Google Scholar

25.Hajsadeghi S, Kerman SR, Khojandi M, Vaferi H. 2012. Accuracy of D-dimer : fibrinogen ratio to diagnose pulmonary thromboembolism in patients admitted to intensive care units : cardiovascular topic. Cardiovasc J Afr., 23(8): 446–56.

View at Google Scholar

26.Ranucci M, Ballotta A, Di Dedda U, Bayshnikova E, Dei Poli M, Resta M, et al. 2020. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost., 18(7): 1747–51.

View at Google Scholar

27.Panigada M, Bottino N, Tagliabue P, Grasselli G, Novembrino C, Chantarangkul V, et al. 2020. Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis. J. Thromb. Haemost., 18(7): 1738–42.

View at Google Scholar

28.Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri FC. 2020. Evaluation of coagulation function by rotation throm-boelastometry in critically ill patients with severe COVID-19 pneumonia. J. Thromb. Thrombolysis., 50(2): 281–6.

View at Google Scholar

29.Chandel A, Patolia S, Looby M, Dalton H, Bade N, Khangoora V, et al. 2020. Association of D-dimer and fibrinogen magnitude with hypercoagulability by thromboelastographyin severe COVID-19 [Internet]. Intensive Care and Critical Care Medicine; 2020 Jul [cited 2020 Dec 7]. Available from: http://medrxiv.org/lookup/ doi/10.1101/2020.07.27.20162842

View at Google Scholar

30.Wise J. 2020. Covid-19 and thrombosis: what do we know about the risks and treatment? BMJ. May 21; m2058.

View at Google Scholar

31.Maier CL, Barker NA, Sniecinski RM. 2020. Falsely Low Fibrinogen Levels in COVID-19 Patients on Direct Thrombin Inhibitors. Anesth Analg., 131(2): e117–9.

View at Google Scholar

32.Osawa I, Okamoto K, Ikeda M, Otani A, Wakimoto Y, Yamashita M, et al. 2020. Dynamic changes in fibrinogen and D-dimer levels in COVID-19 patients on nafamostat mesylate. J Thromb Thrombolysis [Internet]. 2020 Sep 12 [cited 2020 Dec 7]; Available from: http://link.springer. com/10.1007/s11239-020-02275-5

View at Google Scholar

33.Aleman MM, Walton BL, Byrnes JR, Wolberg AS. 2014. Fibrinogen and red blood cells in venous thrombosis. Thromb. Res., 133 Suppl 1:S38-40.

View at Google Scholar

34.Klovaite J, Nordestgaard BG, Tybjærg-Hansen A, Benn M. 2013. Elevated fibrinogen levels are associated with risk of pulmonary embolism, but not with deep venous thrombosis. Am J Respir Crit Care Med., 187(3): 286–93.

View at Google Scholar

35.Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, et al. 2020. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost., 18(5): 1023–6.

View at Google Scholar

36.Eljilany I, Elzouki A-N. 2020. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review. Vasc Health Risk Manag., 16: 455–62.

View at Google Scholar

37.Abbassi-Ghanavati M, Greer LG, Cunningham FG. 2009. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol., 114: 1326-1331.

View at Google Scholar

38.Hager K, Felicetti M, Seefried G, Platt D. 1994. Fibrinogen and aging. Aging (Milano)., 6(2): 133-8.

View at Google Scholar

@Journal of Advances in Medicine(JAM)| Printed by New Delhi Publishers

3518193 - Visitors since March 13, 2019